To include your compound in the COVID-19 Resource Center, submit it here.

Allergy Therapeutics grass pollen program hits snag

Allergy Therapeutics plc (LSE:AGY) lost 3.50p (15%) to 20p on Monday after it

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE